Natera logo

Manager Quality Assurance and Regulatory Affairs

Natera

Any City, USRemotePosted 1 day ago$112,100 - $150,000/year
Full TimeSenior LevelRegulatory AffairsDiagnostics
Original posting ↗

Summary

The Manager, Regulatory Affairs and Quality Assurance (Biologics) drives complex FDA regulatory submissions for biologic programs, from Phase 1 through marketing applications (BLA/NDA). In this role, you will build and own quality systems, translate executive strategy into compliant submissions, and provide regulatory guidance to ensure rapid product approvals. You will coordinate risk assessments balancing technical impact, patient safety, and regulatory compliance.

Job description

Position Summary

The Manager, Regulatory Affairs and Quality Assurance (Biologics) drives complex FDA regulatory submissions for biologic programs, from Phase 1 through marketing applications (BLA/NDA). In this role, you will build and own quality systems, translate executive strategy into compliant submissions, and provide regulatory guidance to ensure rapid product approvals. You will coordinate risk assessments balancing technical impact, patient safety, and regulatory compliance.

Primary Responsibilities

  • Turn executive strategy, development priorities, and target product profiles into actionable regulatory plans and submissions.
  • Apply in-depth knowledge of FDCA, PHS Act Section 351, 21 CFR, and FDA/ICH guidance to build submissions that meet current agency expectations.
  • Guide cross-functional teams in preparation for pre-IND/INTERACT and FDA meeting requests (Type A/B/C/D, pre-BLA/NDA).
  • Author and review CMC (Module 3), nonclinical (Modules 2.4/2.6, 4), or clinical (Modules 2.5/2.7, 5) components of regulatory submissions.
  • Support RA leadership in maintaining INDs, including protocol amendments, safety reports, and change notifications.
  • Prepare briefing materials, question strategies, and tracking minutes for FDA meetings.
  • Draft technical responses to FDA information requests and clinical holds.
  • Represent Regulatory Affairs on program teams to ensure deliverables meet regulatory requirements with the least-burdensome approaches.
  • Own core quality system processes, including CAPA, nonconformance reports (NCRs), change control, and SOP management.
  • Build and maintain agile quality systems that ensure compliance without slowing down our ability to deliver critical products.
  • Support FDA and CDMO inspection readiness (PAI/PLI, BIMO) through mock inspections and document preparation.
  • Manage and develop a team of quality and regulatory professionals as business needs require.

Qualifications

  • B.S., M.S., or equivalent in Life Sciences, Pharmacy, Chemistry, Biochemistry, or Engineering (experience may substitute for education).
  • 5-8 years of biotech or pharma industry experience in regulatory affairs, including Phase 1 IND through marketing application.
  • Biologics experience preferred.
  • Hands-on experience with eCTD and FDA ESG submissions.
  • Working knowledge of FDA biologics regulations (21 CFR Parts 11, 50, 56, 58, 210/211, 312, 600-610) and ICH guidelines.
  • Direct experience managing CAPA, NCR, and change control in an electronic QMS.

Knowledge, Skills, and Abilities

  • Capable of operating independently and building structure where it is missing.
  • Strong scientific writing and risk assessment skills, relying on evidence and data to make decisions.
  • Clear, proactive communicator who adapts quickly to shifting priorities.
  • Experience with CBER- or CDER-regulated biologics (monoclonal antibodies, recombinant proteins, cell/gene therapy).
  • RAC certification or ASQ CQA/CQE is a plus.
  • CDMO oversight and phase-appropriate GMP experience.

Requirements

  • B.S., M.S., or equivalent in Life Sciences, Pharmacy, Chemistry, Biochemistry, or Engineering (experience may substitute for education)
  • 5-8 years of biotech or pharma industry experience in regulatory affairs, including Phase 1 IND through marketing application
  • Hands-on experience with eCTD and FDA ESG submissions
  • Working knowledge of FDA biologics regulations (21 CFR Parts 11, 50, 56, 58, 210/211, 312, 600-610) and ICH guidelines
  • Direct experience managing CAPA, NCR, and change control in an electronic QMS
  • Strong scientific writing and risk assessment skills
  • Clear, proactive communicator who adapts quickly to shifting priorities
  • Capable of operating independently and building structure where it is missing
  • Biologics experience preferred
  • Experience with CBER- or CDER-regulated biologics (monoclonal antibodies, recombinant proteins, cell/gene therapy)
  • RAC certification or ASQ CQA/CQE is a plus
  • CDMO oversight and phase-appropriate GMP experience

Benefits

  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Free Testing
  • Fertility Care Benefits
  • Pregnancy & Baby Bonding Leave
  • 401(k) Benefits
  • Commuter Benefits
  • Employee Referral Program

Company overview

Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in molecular diagnostics for oncology, women's health, and organ health. Founded in 2004 and headquartered in Austin, Texas, the company has developed a cutting-edge cfDNA technology platform that combines novel molecular biology techniques with bioinformatics software and artificial intelligence. Natera's proprietary technology enables detection down to a single molecule in a tube of blood, making it possible to provide highly accurate genetic testing services. The company's flagship products include Signatera, a personalized circulating tumor DNA test for cancer monitoring; Panorama, a non-invasive prenatal test for chromosomal abnormalities; and Prospera, a transplant rejection assessment test. With over 4,400 employees and operations in CLIA-certified, CAP-accredited laboratories in Austin and San Carlos, California, Natera has processed more than 12 million tests and validated its technology through over 300 peer-reviewed publications. The company went public in 2015 and continues to innovate in precision medicine, aiming to make personalized genetic testing part of standard healthcare to enable earlier interventions and improved patient outcomes.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.